The global Softgel Capsules market size is estimated to be valued at US$ 12.1 billion in 2030, and is expected to exhibit a CAGR of 11.0% over the forecast period (2021-2030).
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38680
Growth Factors
Softgel capsules are proven to be the choice of formulation for poorly soluble drugs and enhance absorption time of most drug molecules. Its advantages over tablets and other oral formulations have led to the increased adoption of softgel capsules across the globe. Ease of swallowing, taste masking, improved bioavailability, non-reactive, aesthetically appealing, and longer shelf life are the factors influencing its wide acceptance.
Leading players like Catalent, Eurocaps, and many others, are developing vegan capsules to broaden their vegan consumer base as softgel capsule segment registers nearly 40.0% of their overall revenue
Report Coverage
| Report Scope | Details |
| Market Size | USD 12.1 billion by 2030 |
| Growth Rate | CAGR of 11.0% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Application, Manufacturer |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Fuji Capsules Co Ltd.; Sirio Pharma; Captek; Patheon; Catalent; Eurocaps; Aenova; Capsugel; Procaps Laboratories; Soft gel Technologies Inc. |
Growth Factors
By Application Analysis
The vitamins and dietary supplements segment dominated the market and accounted for the largest revenue share of 26.1% in 2020. Vitamins are prone to atmospheric oxidation and degradation when formulated as tablets or gummies. Hence, softgel capsules are the best formulation choice, as it protects for from UV radiation and oxidation ultimately improving its shelf life.
Health supplements held the second position in the application segment due to increased adoption of healthy lifestyles among masses to tackle the pandemic. Wide acceptance of pre- and post-natal capsules, and inclination towards tasteless medication, led to the increase in sales of softgel capsules, enhancing pregnancy market growth.
By Manufacturer Analysis
The nutraceutical segment accounted for the largest share of 37.6% in 2020. Nutraceutical companies mainly focus on developing vitamins, minerals, and health supplements. Thus, softgel formulation is largely developed to keep up the rising need for nutraceutical products.
The formulations segment accounted for nearly 31% of the total revenue of most nutraceutical manufacturers. Increasing awareness of health supplements among developing nations, a growing number of production houses, and surge in sales due to the COVID-19 pandemic, has led to its high growth and large market share.
By Type Analysis
The gelatin-based/ animal-based segment dominated the market accounted for the largest share of 72.8% in 2020. Over 80 years, gelatin is the choicest excipient of manufacturers due to its unparallel advantages over any other excipient. Ease of digestion, tamper-evident capsule production, superior mechanical resistance and seal quality, patient compliant, abundant resource availability, inert, and clean label raw material, are the factors responsible for its wide acceptance in the market.
Now-a-days, manufacturers are developing capsules using a combination of bovine and porcine gelatin due to their unique properties. Gelatin extracted from bovine enhanced capsule firmness and that from porcine provides plasticity and clarity characteristics to the formulation.
By Regional Analysis
North America dominated the market and accounted for the largest revenue share of 29.1% in 2020. Improved production technology, presence of major players within the region, and increased expenditure on R&D to widen their product portfolio.
The enormous presence of generic medicine manufacturers in China and India, increasing demand for cost-efficient therapeutics, rapidly growing economical conditions, and rise in contract manufacturing organizations within the region, are factors responsible for its high growth.
Key Players
- Fuji Capsules Co Ltd
- Sirio Pharma
- Captek
- Patheon
- Catalent
- Eurocaps
- Aenova
- Capsugel
- Procaps Laboratories
- Soft gel Technologies Inc.
Market Segmentation
- Type
- Gelatin-based/Animal-based
- Non-animal-based
- Application
- Antacid and anti-flatulent preparations
- Anti-anemic preparations
- Anti-inflammatory drugs
- Antibiotic and antibacterial drugs
- Cough and cold preparations
- Health supplement
- Vitamin and dietary supplement
- Pregnancy
- Manufacturers
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organization
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Norway
- Sweden
- Russia
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- UAE
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38680
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Softgel Capsules Market, By Type
7.1. Softgel Capsules Market, by Type, 2021-2030
7.1.1. Gelatin-based/Animal-based
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Non-animal-based
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Softgel Capsules Market, By Application
8.1. Softgel Capsules Market, by Application, 2021-2030
8.1.1. Antacid and anti-flatulent preparations
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Anti-anemic preparations
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Anti-inflammatory drugs
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Antibiotic and antibacterial drugs
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Cough and cold preparations
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Health supplement
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Vitamin and dietary supplement
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Pregnancy
8.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Softgel Capsules Market, By Manufacturers
9.1. Softgel Capsules Market, by Manufacturers, 2021-2030
9.1.1. Pharmaceutical Companies
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Nutraceutical Companies
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Cosmeceutical Companies
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Contract Manufacturing Organization
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Softgel Capsules Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.5.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.7.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.7.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.7.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.5.3. Market Revenue and Forecast, by Manufacturers (2017-2030)
Chapter 11. Company Profiles
11.1. Fuji Capsules Co Ltd
11.1.1. Company Overview
11.1.2. Type Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Sirio Pharma
11.2.1. Company Overview
11.2.2. Type Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Captek
11.3.1. Company Overview
11.3.2. Type Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Patheon
11.4.1. Company Overview
11.4.2. Type Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Catalent
11.5.1. Company Overview
11.5.2. Type Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Eurocaps
11.6.1. Company Overview
11.6.2. Type Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Aenova
11.7.1. Company Overview
11.7.2. Type Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Capsugel
11.8.1. Company Overview
11.8.2. Type Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Procaps Laboratories
11.9.1. Company Overview
11.9.2. Type Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Soft gel Technologies Inc.
11.10.1. Company Overview
11.10.2. Type Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38680
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
Email: sales@visionresearchreports.com
